Skip to menu Skip to content Skip to footer

2009

Journal Article

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

O'Shea, Stacey, Hawley, Carmel M., McDonald, Stephen P., Brown, Fiona G., Rosman, Johan B., Wiggins, Kathryn J., Bannister, Kym M. and Johnson, David W. (2009). Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases. BMC Nephrology, 10 (1) 19, 19.1-19.9. doi: 10.1186/1471-2369-10-19

Streptococcal peritonitis in Australian peritoneal dialysis patients: Predictors, treatment and outcomes in 287 cases

2009

Journal Article

Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients

Orazio, Linda, Hickman, Ingrid, Armstrong, Kirsten, Johnson, David, Banks, Merrilyn and Isbel, Nicole (2009). Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients. Journal Of Renal Nutrition, 19 (4), 304-313. doi: 10.1053/j.jrn.2008.11.006

Higher Levels of Physical Activity Are Associated With a Lower Risk of Abnormal Glucose Tolerance in Renal Transplant Recipients

2009

Journal Article

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

Mudge, David, Tan, Ken-Soon, Miles, Rhianna, Johnson, David W., Campbell, Scott, Hawley, Carmel M., Isbel, Nicole M., Van Eps, Carolyn and Nicol, David L. (2009). Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients. BMC Nephrology, 10 (1) 14, 14.1-14.3. doi: 10.1186/1471-2369-10-14

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

2009

Journal Article

Review article: Addressing risk factors in chronic kidney disease mineral and bone disorder: Can we influence patient-level outcomes?

O'Shea, Stacey and Johnson, David W. (2009). Review article: Addressing risk factors in chronic kidney disease mineral and bone disorder: Can we influence patient-level outcomes?. Nephrology, 14 (4), 416-427. doi: 10.1111/j.1440-1797.2009.01114.x

Review article: Addressing risk factors in chronic kidney disease mineral and bone disorder: Can we influence patient-level outcomes?

2009

Journal Article

Reoperation for Intracranial Hypertension in <i>TWIST1</i>-Confirmed Saethre-Chotzen Syndrome: A 15-Year Review

Woods, Roger H., Ul-Haq, Ehtesham, Wilkie, Andrew O. M., Jayamohan, Jayaratnam, Richards, Peter G., Johnson, David, Lester, Tracy and Wall, Steven A. (2009). Reoperation for Intracranial Hypertension in TWIST1-Confirmed Saethre-Chotzen Syndrome: A 15-Year Review. Plastic and Reconstructive Surgery, 123 (6), 1801-1810. doi: 10.1097/PRS.0b013e3181a3f391

Reoperation for Intracranial Hypertension in <i>TWIST1</i>-Confirmed Saethre-Chotzen Syndrome: A 15-Year Review

2009

Journal Article

Life-threatening adenovirus infection in a kidney transplant recipient

Barraclough, Katherine, Oliver, Kimberley, Playford, Elliot Geoffrey, Preston, John, Campbell, Scott, Johnson, David W., Hawley, Carmel, Mudge, David, van Eps, Carolyn and Isbel, Nicole (2009). Life-threatening adenovirus infection in a kidney transplant recipient. NDT Plus, 2 (3), 250-253. doi: 10.1093/ndtplus/sfp003

Life-threatening adenovirus infection in a kidney transplant recipient

2009

Journal Article

Opinions on the content and effects of clinical practice guidelines for CKD: A survey of nephrologists in Australia and New Zealand

Irving, Michelle J., Johnson, David W., McDonald, Stephen, Walker, Rowan G., Frommer, Michael S. and Craig, Jonathan C. (2009). Opinions on the content and effects of clinical practice guidelines for CKD: A survey of nephrologists in Australia and New Zealand. American Journal of Kidney Diseases, 53 (6), 1082-1090. doi: 10.1053/j.ajkd.2008.12.037

Opinions on the content and effects of clinical practice guidelines for CKD: A survey of nephrologists in Australia and New Zealand

2009

Journal Article

Frontorhiny, a Distinctive Presentation of Frontonasal Dysplasia Caused by Recessive Mutations in the <i>ALX3</i> Homeobox Gene

Twigg, Stephen R. F., Versnel, Sarah L., Nuernberg, Gudrun, Lees, Melissa M., Bhat, Meenakshi, Hammond, Peter, Hennekam, Raoul C. M., Hoogeboom, A. Jeannette M., Hurst, Jane A., Johnson, David, Robinson, Alexis A., Scambler, Peter J., Gerrelli, Dianne, Nuernberg, Peter, Mathijssen, Irene M. J. and Wilkie, Andrew O. M. (2009). Frontorhiny, a Distinctive Presentation of Frontonasal Dysplasia Caused by Recessive Mutations in the ALX3 Homeobox Gene. American Journal of Human Genetics, 84 (5), 698-705. doi: 10.1016/j.ajhg.2009.04.009

Frontorhiny, a Distinctive Presentation of Frontonasal Dysplasia Caused by Recessive Mutations in the <i>ALX3</i> Homeobox Gene

2009

Journal Article

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma

Lopez, Gonzalo, Liu, Juehui, Ren, Wenhong, Wei, Wei, Wang, Suizhao, Lahat, Guy, Zhu, Quan-Sheng, Bornmann, William G., McConkey, David J., Pollock, Raphael E. and Lev, Dina C. (2009). Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma. Clinical Cancer Research, 15 (10), 3472-3483. doi: 10.1158/1078-0432.CCR-08-2714

Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma

2009

Journal Article

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

Johnson, D. W, Clark, C, Isbel, N, Hawley, C, Beller, E, Cass, A, de Zoysa, J, McTaggart, S, Playford, G, Rosser, B, Thompson, C and Snelling, P (2009). The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Peritoneal Dialysis International, 29 (3), 303-309. doi: 10.1177/089686080902900315

The Honeypot study protocol: A randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients

2009

Journal Article

Aminoglycosides in hemodialysis patients: Is the current practice of post dialysis dosing appropriate

O'Shea, Stacey, Duffull, Stephen and Johnson, David W. (2009). Aminoglycosides in hemodialysis patients: Is the current practice of post dialysis dosing appropriate. Seminars in Dialysis, 22 (3), 225-230. doi: 10.1111/j.1525-139X.2008.00554.x

Aminoglycosides in hemodialysis patients: Is the current practice of post dialysis dosing appropriate

2009

Journal Article

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data

Johnson, David W., Dent, Hannah, Yao, Qiang, Tranaeus, Anders, Huang, Chiu-Chin, Han, Dae-Suk, Jha, Vivekanand, Wang, T, Kawaguchi, Yoshindo and Qian, Jiaqi (2009). Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data. Nephrology Dialysis Transplantation, 24 (5), 1598-1603. doi: 10.1093/ndt/gfn684

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data

2009

Journal Article

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

Navaneethan, Sankar D., Pansini, Francesca, Perkovic, Vlado, Manno, Carlo, Pellegrini, Fabio, Johnson, David W., Craig, Jonathan C. and Strippoli, Giovanni F.M. (2009). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews (2) CD007784, 1-53. doi: 10.1002/14651858.cd007784

HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis

2009

Journal Article

Automated reporting of eGFR: A useful tool for identifying and managing kidney disease

Johnson, David W., Jones, Graham R. D., Becker, Gavin J. and Mathew, Timothy H. (2009). Automated reporting of eGFR: A useful tool for identifying and managing kidney disease. Medical Journal of Australia, 190 (4), 200-203. doi: 10.5694/j.1326-5377.2009.tb02349.x

Automated reporting of eGFR: A useful tool for identifying and managing kidney disease

2009

Journal Article

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

Barraclough, K.A., Staatz, C.E., Isbel, N.M. and Johnson, D.W. (2009). Therapeutic monitoring of mycophenolate in transplantation: Is it justified?. Current Drug Metabolism, 10 (2), 179-187. doi: 10.2174/138920009787522205

Therapeutic monitoring of mycophenolate in transplantation: Is it justified?

2009

Journal Article

An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects

Wojcikowski, Ken, Wohlmuth, Hans, Johnson, David W., Rolfe, Margaret and Gobe, Glenda (2009). An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects. Nephrology, 14 (1), 70-79. doi: 10.1111/j.1440-1797.2008.01017.x

An in vitro investigation of herbs traditionally used for kidney and urinary system disorders: Potential therapeutic and toxic effects

2009

Journal Article

Rare Mutations of <i>FGFR2</i> Causing Apert Syndrome: Identification of the First Partial Gene Deletion, and an <i>Alu</i> Element Insertion From a New Subfamily

Bochukova, Elena G., Roscioli, Tony, Hedges, Dale J., Taylor, Indira B., Johnson, David, David, David J., Deininger, Prescott L. and Wilkie, Andrew O. M. (2009). Rare Mutations of FGFR2 Causing Apert Syndrome: Identification of the First Partial Gene Deletion, and an Alu Element Insertion From a New Subfamily. Human Mutation, 30 (2), 204-211. doi: 10.1002/humu.20825

Rare Mutations of <i>FGFR2</i> Causing Apert Syndrome: Identification of the First Partial Gene Deletion, and an <i>Alu</i> Element Insertion From a New Subfamily

2009

Journal Article

Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases

Barraclough, K., Hawley, C. M., McDonald, SP, Brown, F. G, Rosman, J. B., Wiggins, K. J., Bannister, K. M. and Johnson, D. W. (2009). Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrology Dialysis Transplantation, 24 (12), 3834-3839. doi: 10.1093/ndt/gfp322

Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases

2009

Journal Article

Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients

Miles, R., Hawley, C. M., McDonald, S. P., Brown, F. G., Rosman, J. B., Wiggins, K. J., Bannister, K. M. and Johnson, D. W. (2009). Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney International, 76 (6), 622-628. doi: 10.1038/ki.2009.202

Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients

2009

Journal Article

Relationship between dialysis modality and mortality

McDonald, Stephen P., Marshall, Mark R., Johnson, David W. and Polkinghorne, Kevan R. (2009). Relationship between dialysis modality and mortality. Journal of the American Society of Nephrology, 20 (1), 155-163. doi: 10.1681/ASN.2007111188

Relationship between dialysis modality and mortality